Friday, October 31, 2008
14194

Tissue-Engineered Scaffolds for Alveolar Bone Regeneration in a Gingivoperiosteoplasty Model

Phuong D. Nguyen, MD, Clarence D. Lin, MA, Alexander C. Allori, MD, MPH, Tom Reisler, MD, Jeffrey S. Schachar, BS, Jamie P. Levine, MD, Pierre B. Saadeh, MD, and Stephen M. Warren, MD.

Intro: Primary alveolar cleft repair treating congenital alveolar clefts with gingivoperiosteoplasty (GPP) has a 60% success rate. The remaining 40% have persistent alveolar bony defects requiring secondary grafting, which is associated with donor-site morbidity, graft resorption, and infection, and bone or tooth loss.  Herein, we describe a novel critical-size defect GPP model using tissue-engineered scaffolds to improve bone regeneration and circumvent secondary grafting.

Methods: A 7x4x3-mm complete alveolar defect was surgically created in sixty 8-week old rats. Four scaffolds were tested within the defect: absorbable collagen sponge (ACS), ACS+BMP, hydroxyapatite-tricalcium phosphate (HA-TCP), HA-TCP+BMP, and no scaffold as control.  Animals were sacrificed at post-operative weeks 4, 8, and 12.  New bone was assessed histmorphometrically via micro CT. Decalcified sections were processed for histology.

Results:  Morphometric analysis demonstrated regeneration in negative control groups to 43±10% at 4 weeks, but plateaued to 53±17% at 8 weeks and 48±6% at 12 weeks .  ACS groups showed 50±12% at 4 weeks and 79±19% at 8 weeks and 69±12% at 12 weeks. ACS+BMP regeneration was 49±4% and 71±13%, and 66±13%, respectively.  HA-TCP displayed 69±20% bone growth at 4 weeks and plateaued to 86±6% (p<0.05) at 8 weeks and 87±25% at 12 weeks, while adding BMP yielded 55±29%, 91±5% (p<0.05) and 90±1% (p<0.05) at 12 weeks.  Histologically, HA-TCP groups stimulated appositional bone growth around scaffold granules.  Four weeks showed activated osteoblasts, osteoprogenitor cells, and nascent bone along leading edges of bone spicules, while weeks 8 and 12 showed denser fibroblasts and maturing bone in the form of well-formed osteocytes.

Conclusions: HA-TCP shows greater osteogenic capability than ACS.  BMP did not affect significant bone growth increases, perhaps due to lack of a sustained release system. The inherent osteoconductive properties of HA-TCP and its ability to provide for tissue guided regeneration (as opposed to an absorbable matrix) may have contributed to defect healing.